The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Nimenrix

5 microgram(s) Powder and solvent for solution for injection

Pfizer Europe MA EEIGEU/1/12/767/001-007

Main Information

Trade NameNimenrix
Active SubstancesN.meningitidis serogroup a polysaccharide conjugated to tetanus toxoid
N.meningitidis serogroup c polysaccharide conjugated to tetanus toxoid
N.meningitidis serogroup w polysaccharide conjugated to tetanus toxoid
N.meningitidis serogroup y polysaccharide conjugated to tetanus toxoid
Strength5 microgram(s)
Dosage FormPowder and solvent for solution for injection
Licence HolderPfizer Europe MA EEIG
Licence NumberEU/1/12/767/001-007

Group Information

ATC CodeJ07AH Meningococcal vaccines
J07AH08 meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated

Status

Authorised/WithdrawnAuthorised
Licence Issued20/04/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back